Your browser doesn't support javascript.
loading
An international research agenda for clozapine-resistant schizophrenia.
Luykx, Jurjen J; Gonzalez-Diaz, Jairo M; Guu, Ta-Wei; van der Horst, Marte Z; van Dellen, Edwin; Boks, Marco P; Guloksuz, Sinan; DeLisi, Lynn E; Sommer, Iris E; Cummins, Russel; Shiers, David; Lee, Jimmy; Every-Palmer, Susanna; Mhalla, Ahmed; Chadly, Zohra; Chan, Sherry K W; Cotes, Robert O; Takahashi, Shun; Benros, Michael E; Wagner, Elias; Correll, Christoph U; Hasan, Alkomiet; Siskind, Dan; Endres, Dominique; MacCabe, James; Tiihonen, Jari.
Afiliação
  • Luykx JJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, Netherlands; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands; GGNet Mental Health
  • Gonzalez-Diaz JM; Barcelona Clínic Schizophrenia Unit, Neurosciences Institute, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain; UR Center for Mental Health, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia; Clínica Nuestra Señora de la Paz, Orden Hospitalaria de San Juan
  • Guu TW; Department of Old Age Psychiatry, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK; Division of Psychiatry, Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan.
  • van der Horst MZ; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands; GGNet Mental Health, Warnsveld, Netherlands.
  • van Dellen E; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands; Department of Intensive Care Medicine, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands; Department of Neurology, UZ B
  • Boks MP; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Guloksuz S; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, Netherlands; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • DeLisi LE; Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA.
  • Sommer IE; Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Cummins R; Utrecht, Netherlands.
  • Shiers D; Psychosis Research Unit, Greater Manchester Mental Health NHS Trust, Manchester, UK.
  • Lee J; Department of Psychosis, Institute of Mental Health, Singapore; Neuroscience and Mental Health, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
  • Every-Palmer S; Department of Psychological Medicine, University of Otago Wellington, Wellington, New Zealand.
  • Mhalla A; Department of Psychiatry, Fattouma Bourguiba Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia.
  • Chadly Z; Department of Pharmacology, Fattouma Bourguiba Hospital, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia.
  • Chan SKW; Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China; State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Cotes RO; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
  • Takahashi S; Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan; Graduate School of Rehabilitation Science, Osaka Metropolitan University, Habikino, Japan; Clinical Research and Education Center, Asakayama General Hospital, Sakai, Japan; Department of Neuropsychiatry, Wakayama M
  • Benros ME; Biological and Precision Psychiatry, Copenhagen Research Center for Mental Health, Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark; Department of Immunology and Microbiology, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
  • Wagner E; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Correll CU; Department of Child and Adolescent Psychiatry, Charité Universitaetsmedizin Berlin, Berlin, Germany; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Department of Psychiatry, The Zucker Hillside Hospital, Northwe
  • Hasan A; Department of Psychiatry, Psychotherapy and Psychosomatics, University of Augsburg, Medical Faculty, Augsburg, Germany.
  • Siskind D; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; Metro South Addiction and Mental Health Service, Brisbane, QLD, Australia.
  • Endres D; Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • MacCabe J; Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
  • Tiihonen J; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; Department of Clinical Neuroscience, Karolinska Institutet, and Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden.
Lancet Psychiatry ; 10(8): 644-652, 2023 08.
Article em En | MEDLINE | ID: mdl-37329895

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudo: Guideline / Screening_studies Limite: Humans Idioma: En Revista: Lancet Psychiatry Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Tipo de estudo: Guideline / Screening_studies Limite: Humans Idioma: En Revista: Lancet Psychiatry Ano de publicação: 2023 Tipo de documento: Article